MASON YU: Open Payments
NPI 1477150795 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,587 in 74 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $1,587
Food & beverage: $1,587
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $671 |
| Janssen Biotech, Inc. | 5 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $128 |
| EVOKE PHARMA, INC. | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 3 | $76 |
| Madrigal Pharmaceuticals | 2 | $62 |
| Gilead Sciences, Inc. | 3 | $55 |
| GENZYME CORPORATION | 2 | $53 |
| Lilly USA, LLC | 2 | $43 |
Products named: RINVOQ, LINZESS, TREMFYA, SKYRIZI, ENTYVIO, XIFAXAN, CREON, GIMOTI.
Industry payments across TX — which companies pay providers there.
